Ji Xu, Zhang Xinyue Elyse, Yabroff K Robin, Stock Wendy, Cornwell Patricia, Bai Shasha, Mertens Ann C, Lipscomb Joseph, Castellino Sharon M
Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
Aflac Cancer & Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, USA.
J Natl Cancer Inst. 2025 Feb 1;117(2):344-354. doi: 10.1093/jnci/djae226.
Many uninsured patients do not receive Medicaid coverage until a cancer diagnosis, potentially delaying access to care for early cancer detection and treatment. We examined the association of Medicaid enrollment timing and patterns with survival among children, adolescents, and young adults with diagnosed blood cancers, where disease onset can be acute and early detection is critical.
We identified 28 750 children, adolescents, and young adults (birth to 39 years of age) with newly diagnosed blood cancers from the 2006-2013 Surveillance, Epidemiology, and End Results program-Medicaid data. Enrollment patterns included continuous Medicaid enrollment (preceding through diagnosis), newly gained Medicaid coverage (at or shortly after diagnosis), other noncontinuous Medicaid enrollment, and private/other insurance. We assessed cumulative incidence of death from diagnosis, censoring at last follow-up, 5 years after diagnosis, or December 2018, whichever occurred first. Multivariable survival models estimated the association of insurance enrollment patterns with risk of death.
One-fourth (26.1%) of the cohort was insured by Medicaid; of these patients, 41.1% had continuous Medicaid enrollment, 34.9% had newly gained Medicaid, and 24.0% had other or noncontinuous enrollment. The cumulative incidence of all-cause death 5 year after diagnosis was highest in patients with newly gained Medicaid (30.2%, 95% confidence interval [CI] = 28.4% to 31.9%), followed by other noncontinuous enrollment (23.2%, 95% CI = 21.3% to 25.2%), continuous Medicaid enrollment (20.5%, 95% CI = 19.1% to 21.9%), and private/other insurance (11.2%, 95% CI = 10.7% to 11.7%). In multivariable models, newly gained Medicaid was associated with a higher risk of all-cause death (hazard ratio = 1.39, 95% CI = 1.27 to 1.53) and cancer-specific death (hazard ratio = 1.50, 95% CI = 1.35 to 1.68) compared with continuous Medicaid.
Continuous Medicaid coverage is associated with survival benefits among pediatric, adolescent, and young adult patients with diagnosed blood cancers; however, fewer than half of Medicaid-insured patients have continuous coverage before diagnosis.
许多未参保患者直到被诊断出患有癌症才获得医疗补助覆盖,这可能会延迟早期癌症检测和治疗的就医机会。我们研究了医疗补助参保时间和模式与确诊血液癌症的儿童、青少年和青年患者生存率之间的关联,这类疾病起病可能很急,早期检测至关重要。
我们从2006 - 2013年监测、流行病学和最终结果计划 - 医疗补助数据中确定了28750名新诊断出血液癌症的儿童、青少年和青年(出生至39岁)。参保模式包括持续医疗补助参保(诊断前持续参保)、新获得医疗补助覆盖(诊断时或诊断后不久)、其他非持续医疗补助参保以及私人/其他保险。我们评估了从诊断开始的累积死亡发生率,在最后一次随访、诊断后5年或2018年12月(以先发生者为准)进行截尾。多变量生存模型估计了保险参保模式与死亡风险之间的关联。
队列中有四分之一(26.1%)的人由医疗补助承保;在这些患者中,41.1%有持续医疗补助参保,34.9%新获得了医疗补助,24.0%有其他或非持续参保。诊断后5年全因死亡的累积发生率在新获得医疗补助的患者中最高(30.2%,95%置信区间[CI]=28.4%至31.9%),其次是其他非持续参保(23.2%,95%CI=21.3%至25.2%)、持续医疗补助参保(20.5%,95%CI=19.1%至21.9%)以及私人/其他保险(11.2%,95%CI=10.7%至11.7%)。在多变量模型中,与持续医疗补助相比,新获得医疗补助与更高的全因死亡风险(风险比=1.39,95%CI=1.27至1.53)和癌症特异性死亡风险(风险比=1.50,95%CI=1.35至1.68)相关。
持续医疗补助覆盖与确诊血液癌症的儿科、青少年和青年患者的生存获益相关;然而,不到一半的医疗补助参保患者在诊断前有持续覆盖。